Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
GlaxoSmithKline call volume above normal and directionally bullish » 11:25
10/22/21
10/22
11:25
10/22/21
11:25
GSK

GlaxoSmithKline

$39.71 /

+0.16 (+0.40%)

Bullish option flow…

Bullish option flow detected in GlaxoSmithKline with 9,054 calls trading, 5x expected, and implied vol increasing almost 2 points to 22.20%. are the most active options, with total volume in those strikes near 0 contracts. The Put/Call Ratio is 0.03. Earnings are expected on October 27th.

ShowHide Related Items >><<
GSK GlaxoSmithKline
$39.71 /

+0.16 (+0.40%)

GSK GlaxoSmithKline
$39.71 /

+0.16 (+0.40%)

10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/04/21 Alliance Global Partners
Achieve Life Sciences initiated with a Buy at Alliance Global Partners
GSK GlaxoSmithKline
$39.71 /

+0.16 (+0.40%)

GSK GlaxoSmithKline
$39.71 /

+0.16 (+0.40%)

GSK GlaxoSmithKline
$39.71 /

+0.16 (+0.40%)

GSK GlaxoSmithKline
$39.71 /

+0.16 (+0.40%)

Hot Stocks
Walgreens says now offering Moderna, J&J vaccine booster shots nationwide » 09:32
10/22/21
10/22
09:32
10/22/21
09:32
WBA

Walgreens Boots Alliance

$49.16 /

+0.77 (+1.59%)

, MRNA

Moderna

$339.49 /

+6.68 (+2.01%)

, JNJ

Johnson & Johnson

$163.32 /

-0.44 (-0.27%)

, PFE

Pfizer

$42.86 /

+0.07 (+0.16%)

Walgreens (WBA) announced…

Walgreens (WBA) announced that eligible individuals can now receive Moderna (MRNA) and Johnson & Johnson (JNJ) COVID-19 vaccine booster shots in stores nationwide following the Food and Drug Administration Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention. This follows FDA authorization of a Pfizer (PFE) booster dose on Sept. 24. As part of this new guidance, eligible populations may also choose to receive a dose different from the one they received for their initial series, Walgreens noted.

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$49.16 /

+0.77 (+1.59%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MRNA Moderna
$339.49 /

+6.68 (+2.01%)

JNJ Johnson & Johnson
$163.32 /

-0.44 (-0.27%)

WBA Walgreens Boots Alliance
$49.16 /

+0.77 (+1.59%)

10/15/21 Truist
Walgreens Boots Alliance price target raised to $56 from $52 at Truist
07/06/21 Barclays
Walgreens Boots Alliance price target lowered to $53 from $55 at Barclays
07/02/21 Truist
Walgreens Boots Alliance price target lowered to $52 from $58 at Truist
07/02/21 Deutsche Bank
Walgreens Boots Alliance price target lowered to $52 from $55 at Deutsche Bank
MRNA Moderna
$339.49 /

+6.68 (+2.01%)

10/22/21 Deutsche Bank
Moderna initiated with a Sell at Deutsche Bank
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
JNJ Johnson & Johnson
$163.32 /

-0.44 (-0.27%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
PFE Pfizer
$42.86 /

+0.07 (+0.16%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
WBA Walgreens Boots Alliance
$49.16 /

+0.77 (+1.59%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MRNA Moderna
$339.49 /

+6.68 (+2.01%)

JNJ Johnson & Johnson
$163.32 /

-0.44 (-0.27%)

WBA Walgreens Boots Alliance
$49.16 /

+0.77 (+1.59%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MRNA Moderna
$339.49 /

+6.68 (+2.01%)

JNJ Johnson & Johnson
$163.32 /

-0.44 (-0.27%)

WBA Walgreens Boots Alliance
$49.16 /

+0.77 (+1.59%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MRNA Moderna
$339.49 /

+6.68 (+2.01%)

JNJ Johnson & Johnson
$163.32 /

-0.44 (-0.27%)

WBA Walgreens Boots Alliance
$49.16 /

+0.77 (+1.59%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MRNA Moderna
$339.49 /

+6.68 (+2.01%)

JNJ Johnson & Johnson
$163.32 /

-0.44 (-0.27%)

Hot Stocks
Pfizer, BioNTech Covid vaccine 90.7% effective in children, FDA says » 08:05
10/22/21
10/22
08:05
10/22/21
08:05
PFE

Pfizer

$42.86 /

+0.07 (+0.16%)

, BNTX

BioNTech

$286.47 /

+16.78 (+6.22%)

In briefing documents…

In briefing documents ahead of the advisory panel meeting on October 26, the FDA said Pfizer (PFE) and BioNTech's (BNTX) vaccine efficacy against laboratory-confirmed symptomatic Covid-19 occurring at least seven days after dose two in evaluable participants aged 5 to 11 without evidence of prior SARS-CoV-2 infection was 90.7%. There were no cases of severe Covid-19 and no cases of MIS-C reported as of the data cutoff date. It is notable that the earliest reported and confirmed Covid-19 case in this analysis was in July, with most occurring in August and September, therefore all confirmed cases have been reported during a time that the highly transmissible delta has been the predominant SARS-CoV-2 strain in circulation in the U.S. and globally the FDA added. "These data show that the two-dose primary series of BNT162b2 10 microgram given to children 5 to less than12 years of age confers a high degree of protective efficacy against COVID-19 during a period when the Delta variant of concern predominates in the US," it said. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$42.86 /

+0.07 (+0.16%)

BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

10/22/21 Deutsche Bank
BioNTech initiated with a Hold at Deutsche Bank
10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
PFE Pfizer
$42.86 /

+0.07 (+0.16%)

BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

Hot Stocks
Regeneron, Sanofi announce Dupixent trial met primary and secondary endpoints » 05:14
10/22/21
10/22
05:14
10/22/21
05:14
REGN

Regeneron

$569.17 /

+6.94 (+1.23%)

, SNY

Sanofi

$49.20 /

+0.07 (+0.14%)

Regeneron (REGN) and…

Regeneron (REGN) and Sanofi (SNY) positive pivotal Phase 3 results from a trial evaluating Dupixent in adults with uncontrolled prurigo nodularis, a chronic type 2 inflammatory skin disease that causes extreme itch and skin lesions. The trial met its primary and all key secondary endpoints, showing that Dupixent significantly reduced itch and skin lesions compared to placebo in this investigational setting. The impact of uncontrolled prurigo nodularis on quality of life is one of the highest among inflammatory skin diseases with intense, chronic itch. In the Phase 3 PRIME2 trial, topline results comparing Dupixent to placebo showed: 37% of Dupixent patients experienced a clinically meaningful reduction in itch from baseline compared to 22% of placebo patients at week 12, the primary endpoint. At week 24, nearly three times as many Dupixent patients experienced a clinically meaningful reduction in itch from baseline: 58% of Dupixent patients compared to 20% of placebo patients. At week 24, nearly three times as many Dupixent patients achieved clear or almost clear skin: 45% of Dupixent patients compared to 16% of placebo patients. Dupixent patients experienced significantly greater improvements in measures of health-related quality of life, skin pain and symptoms of anxiety and depression. The safety results of the trial were generally consistent with the known safety profile of Dupixent in its approved indications. The occurrences of treatment-emergent adverse events were generally similar between Dupixent and placebo groups. Rates of conjunctivitis and herpes viral infections were similar to what was previously observed in atopic dermatitis trials, and there was a numerically lower rate of skin infections observed with Dupixent. Additionally, 3% of Dupixent patients and 30% of placebo patients discontinued prior to week 24. An additional trial in the LIBERTY-PN PRIME clinical program, PRIME, is fully enrolled. PRIME has a similar trial design and is expected to read out in in the first half of 2022. Regeneron and Sanofi plan to begin regulatory submissions in 2022. The potential use of Dupixent in prurigo nodularis is currently under clinical development, and the safety and efficacy have not been fully evaluated by any regulatory authority.

ShowHide Related Items >><<
SNY Sanofi
$49.20 /

+0.07 (+0.14%)

REGN Regeneron
$569.17 /

+6.94 (+1.23%)

REGN Regeneron
$569.17 /

+6.94 (+1.23%)

10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
10/04/21 H.C. Wainwright
Regeneron selloff brings 'excellent entry point,' says H.C. Wainwright
10/01/21 Piper Sandler
Piper says view on Regeneron antibody 'less certain' after Merck 'game changer'
SNY Sanofi
$49.20 /

+0.07 (+0.14%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SNY Sanofi
$49.20 /

+0.07 (+0.14%)

REGN Regeneron
$569.17 /

+6.94 (+1.23%)

SNY Sanofi
$49.20 /

+0.07 (+0.14%)

REGN Regeneron
$569.17 /

+6.94 (+1.23%)

SNY Sanofi
$49.20 /

+0.07 (+0.14%)

REGN Regeneron
$569.17 /

+6.94 (+1.23%)

REGN Regeneron
$569.17 /

+6.94 (+1.23%)

Thursday
On The Fly
Wall Street in Fives - Must Read Lists for Thursday » 16:38
10/21/21
10/21
16:38
10/21/21
16:38
TSLA

Tesla

$893.61 /

+28.625 (+3.31%)

, T

AT&T

$25.75 /

-0.15 (-0.58%)

, IBM

IBM

$128.31 /

-13.48 (-9.51%)

, PFE

Pfizer

$42.86 /

+0.07 (+0.16%)

, BNTX

BioNTech

$286.47 /

+16.78 (+6.22%)

, DWAC

Digital World Acquisition

$45.77 /

+35.81 (+359.54%)

, LPSN

LivePerson

$53.46 /

-3.68 (-6.44%)

, PLD

Prologis

$144.96 /

+1.54 (+1.07%)

, DENN

Denny's

$15.40 /

+0.8 (+5.48%)

, TCRR

TCR2 Therapeutics

$6.84 /

-0.33 (-4.60%)

, VALE

Vale

$13.36 /

-0.485 (-3.50%)

, DIDI

Didi

$9.81 /

+1.195 (+13.88%)

, AMZN

Amazon.com

$3,437.05 /

+24.73 (+0.72%)

, MU

Micron

$68.63 /

+0.34 (+0.50%)

, INTC

Intel

$56.01 /

+0.61 (+1.10%)

, RCI

Rogers Communications

$48.63 /

-1.03 (-2.07%)

, TSC

TriState Capital

$31.03 /

+8.295 (+36.49%)

, KDMN

Kadmon

$9.42 /

+0.845 (+9.85%)

, SKLZ

Skillz

$9.95 /

+0.78 (+8.51%)

, MTCH

Match Group

$175.65 /

+16.58 (+10.42%)

, SHPW

Shapeways

$9.65 /

-1.19 (-10.98%)

, AN

AutoNation

$125.99 /

+8.87 (+7.57%)

, CROX

Crocs

$148.57 /

+12.29 (+9.02%)

, EFX

Equifax

$255.57 /

-14.195 (-5.26%)

, FCX

Freeport McMoRan

$38.43 /

-0.5 (-1.28%)

, UNP

Union Pacific

$231.36 /

+3.37 (+1.48%)

, BMBL

Bumble

$56.27 /

+3.91 (+7.47%)

, RBLX

Roblox

$83.16 /

+4.495 (+5.71%)

, SPOT

Spotify

$254.98 /

+3.88 (+1.55%)

, ZNGA

Zynga

$7.80 /

+0.06 (+0.78%)

Get caught up quickly on…

ShowHide Related Items >><<
ZNGA Zynga
$7.80 /

+0.06 (+0.78%)

VALE Vale
$13.36 /

-0.485 (-3.50%)

UNP Union Pacific
$231.36 /

+3.37 (+1.48%)

TSLA Tesla
$893.61 /

+28.625 (+3.31%)

TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

TCRR TCR2 Therapeutics
$6.84 /

-0.33 (-4.60%)

T AT&T
$25.75 /

-0.15 (-0.58%)

SPOT Spotify
$254.98 /

+3.88 (+1.55%)

SKLZ Skillz
$9.95 /

+0.78 (+8.51%)

SHPW Shapeways
$9.65 /

-1.19 (-10.98%)

RCI Rogers Communications
$48.63 /

-1.03 (-2.07%)

RBLX Roblox
$83.16 /

+4.495 (+5.71%)

PLD Prologis
$144.96 /

+1.54 (+1.07%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MU Micron
$68.63 /

+0.34 (+0.50%)

MTCH Match Group
$175.65 /

+16.58 (+10.42%)

LPSN LivePerson
$53.46 /

-3.68 (-6.44%)

KDMN Kadmon
$9.42 /

+0.845 (+9.85%)

INTC Intel
$56.01 /

+0.61 (+1.10%)

IBM IBM
$128.31 /

-13.48 (-9.51%)

FCX Freeport McMoRan
$38.43 /

-0.5 (-1.28%)

EFX Equifax
$255.57 /

-14.195 (-5.26%)

DWAC Digital World Acquisition
$45.77 /

+35.81 (+359.54%)

DIDI Didi
$9.81 /

+1.195 (+13.88%)

DENN Denny's
$15.40 /

+0.8 (+5.48%)

CROX Crocs
$148.57 /

+12.29 (+9.02%)

BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

BMBL Bumble
$56.27 /

+3.91 (+7.47%)

AN AutoNation
$125.99 /

+8.87 (+7.57%)

AMZN Amazon.com
$3,437.05 /

+24.73 (+0.72%)

TSLA Tesla
$893.61 /

+28.625 (+3.31%)

10/21/21 RBC Capital
Tesla price target raised to $800 from $755 at RBC Capital
10/21/21 Credit Suisse
Tesla price target raised to $830 from $800 at Credit Suisse
10/21/21 Wedbush
Tesla price target raised to $1,100 from $1,000 at Wedbush
10/21/21 Roth Capital
Tesla price target raised to $250 from $150 at Roth Capital
T AT&T
$25.75 /

-0.15 (-0.58%)

10/19/21 Citi
AT&T price target lowered to $30 from $32 at Citi
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
IBM IBM
$128.31 /

-13.48 (-9.51%)

10/21/21 Morgan Stanley
IBM's Q3 'a pause on the path to improving growth,' says Morgan Stanley
10/06/21 Evercore ISI
IBM removed from Tactical Outperform list at Evercore ISI
10/05/21 Credit Suisse
IBM price target raised to $176 from $167 at Credit Suisse
10/01/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$42.86 /

+0.07 (+0.16%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

10/22/21 Deutsche Bank
BioNTech initiated with a Hold at Deutsche Bank
10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
DWAC Digital World Acquisition
$45.77 /

+35.81 (+359.54%)

LPSN LivePerson
$53.46 /

-3.68 (-6.44%)

10/21/21
Fly Intel: Top five analyst downgrades
10/21/21 Barclays
LivePerson downgraded to Underweight from Overweight at Barclays
09/17/21 Barclays
LivePerson price target raised to $80 from $76 at Barclays
07/01/21
Fly Intel: Top five analyst initiations
PLD Prologis
$144.96 /

+1.54 (+1.07%)

10/21/21
Fly Intel: Top five analyst upgrades
10/21/21 Goldman Sachs
Prologis upgraded to Conviction Buy from Buy at Goldman Sachs
10/20/21 BTIG
Prologis price target raised to $161 from $146 at BTIG
10/19/21 Barclays
Prologis price target raised to $161 from $159 at Barclays
DENN Denny's
$15.40 /

+0.8 (+5.48%)

10/21/21 Truist
Denny's upgraded to Buy from Hold at Truist
10/20/21 Truist
Denny's upgraded to Buy from Hold at Truist
10/08/21
Fly Intel: Top five analyst initiations
10/08/21 Deutsche Bank
Denny's initiated with Hold, $17 target at Deutsche Bank
TCRR TCR2 Therapeutics
$6.84 /

-0.33 (-4.60%)

10/21/21 BMO Capital
TCR2 Therapeutics price target lowered to $38 from $44 at BMO Capital
10/21/21 Mizuho
TCR2 Therapeutics price target lowered to $20 from $51 at Mizuho
10/21/21 SVB Leerink
SVB Leerink downgrades TCR2 on 'protracted road' to recovery
10/20/21 SVB Leerink
TCR2 Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
VALE Vale
$13.36 /

-0.485 (-3.50%)

10/21/21 RBC Capital
Vale double-downgraded to Underperform from Outperform at RBC Capital
10/21/21 RBC Capital
Vale downgraded to Underperform from Outperform at RBC Capital
10/20/21 Jefferies
Jefferies downgrades trio of iron ore miners on near-term downside risk
10/20/21 Jefferies
Vale downgraded to Hold from Buy at Jefferies
DIDI Didi
$9.81 /

+1.195 (+13.88%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
AMZN Amazon.com
$3,437.05 /

+24.73 (+0.72%)

10/22/21 Credit Suisse
Amazon price target lowered to $4,200 from $4,700 at Credit Suisse
10/21/21 Baird
Amazon executive commentary on supply chain 'largely positive,' says Baird
10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
10/20/21 Bernstein
Amazon.com may be more sheltered from broader sector declines, says Bernstein
MU Micron
$68.63 /

+0.34 (+0.50%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
INTC Intel
$56.01 /

+0.61 (+1.10%)

10/22/21 Citi
Intel price target lowered to $52 from $57 at Citi
10/22/21 Roth Capital
Intel price target lowered to $53 from $60 at Roth Capital
10/22/21 Goldman Sachs
Intel price target lowered to $44 from $51 at Goldman Sachs
10/22/21 Truist
Intel price target lowered to $52 from $60 at Truist
RCI Rogers Communications
$48.63 /

-1.03 (-2.07%)

10/12/21 BMO Capital
Rogers Communications price target lowered to $68 from $72 at BMO Capital
10/05/21 JPMorgan
Rogers underperformance brings attractive entry point, says JPMorgan
09/17/21 Morgan Stanley
Morgan Stanley ups Shaw target to C$40.50, names as catalyst driven idea
09/09/21 TD Securities
Rogers Communications resumed with a Buy at TD Securities
TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

10/22/21 B. Riley
TriState Capital downgraded to Neutral on takeover at B. Riley
10/22/21 B. Riley
TriState Capital downgraded to Neutral from Buy at B. Riley
07/23/21 B. Riley
TriState Capital price target raised to $28 from $26 at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy on share pullback at B. Riley
KDMN Kadmon
$9.42 /

+0.845 (+9.85%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 Jefferies
Kadmon downgraded to Hold from Buy at Jefferies
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
SKLZ Skillz
$9.95 /

+0.78 (+8.51%)

08/04/21 Canaccord
Skillz price target lowered to $23 from $30 at Canaccord
08/04/21 Wedbush
Skillz price target lowered to $25 from $34 at Wedbush
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 RBC Capital
Skillz initiated with a Sector Perform at RBC Capital
MTCH Match Group
$175.65 /

+16.58 (+10.42%)

10/12/21 Jefferies
Jefferies positive on Q3 set-up for Match Group and Bumble
08/05/21 Morgan Stanley
Morgan Stanley buyers of Match Group on post-earnings pullback
07/21/21 Truist
Match Group price target raised to $190 from $160 at Truist
07/09/21
Fly Intel: Top five analyst initiations
SHPW Shapeways
$9.65 /

-1.19 (-10.98%)

07/28/21 Lake Street
Galileo Acquisition Corp. initiated with a Buy at Lake Street
AN AutoNation
$125.99 /

+8.87 (+7.57%)

10/22/21 Truist
AutoNation price target raised to $130 from $110 at Truist
09/28/21 Morgan Stanley
AutoNation upgraded to Equal Weight from Underweight at Morgan Stanley
07/20/21 Truist
AutoNation price target raised to $110 from $100 at Truist
07/16/21 BofA
AutoNation price target raised to $171 from $161 at BofA
CROX Crocs
$148.57 /

+12.29 (+9.02%)

10/22/21 Stifel
Crocs price target raised to $157 from $151 at Stifel
10/21/21 Baird
Crocs price target raised to $250 from $215 at Baird
10/21/21 Baird
Baird names Crocs as Fresh Pick, ups price target to $250 from $215
10/21/21 Piper Sandler
Crocs price target raised to $215 from $212 at Piper Sandler
EFX Equifax
$255.57 /

-14.195 (-5.26%)

10/22/21 Argus
Equifax upgraded to Buy from Hold at Argus
10/22/21 Argus
Equifax upgraded to Buy from Hold at Argus
10/22/21 Truist
Equifax price target raised to $245 from $235 at Truist
10/14/21 Evercore ISI
Equifax resumed with an Outperform at Evercore ISI
FCX Freeport McMoRan
$38.43 /

-0.5 (-1.28%)

10/22/21 Argus
Freeport McMoRan price target raised to $45 from $40 at Argus
10/22/21 Deutsche Bank
Freeport McMoRan downgraded to Hold from Buy at Deutsche Bank
10/06/21 Exane BNP Paribas
Freeport McMoRan upgraded to Outperform from Neutral at Exane BNP Paribas
09/29/21 BofA
Freeport McMoRan reinstated with a Buy at BofA
UNP Union Pacific
$231.36 /

+3.37 (+1.48%)

10/22/21 Deutsche Bank
Union Pacific price target raised to $261 from $225 at Deutsche Bank
10/08/21
Fly Intel: Top five analyst upgrades
10/08/21 JPMorgan
Union Pacific upgraded to Overweight on recent selloff at JPMorgan
10/08/21 JPMorgan
Union Pacific upgraded to Overweight from Neutral at JPMorgan
BMBL Bumble
$56.27 /

+3.91 (+7.47%)

07/13/21 Loop Capital
Bumble price target raised to $54 from $45 at Loop Capital
07/09/21 RBC Capital
Bumble initiated with an Outperform at RBC Capital
RBLX Roblox
$83.16 /

+4.495 (+5.71%)

09/20/21 Jefferies
Roblox price target lowered to $86 from $92 at Jefferies
09/15/21 Benchmark
Benchmark reiterates Sell rating on Roblox after 'weak' August indicators
09/15/21 Truist
Roblox key performance indicators for August 'solid,' says Truist
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
SPOT Spotify
$254.98 /

+3.88 (+1.55%)

09/24/21 DZ Bank
Spotify initiated with a Sell at DZ Bank
09/13/21 Goldman Sachs
Spotify initiated with a Neutral at Goldman Sachs
09/07/21
Fly Intel: Top five analyst upgrades
09/07/21 KeyBanc
Spotify upgraded to Overweight on favorable dynamics at KeyBanc
ZNGA Zynga
$7.80 /

+0.06 (+0.78%)

09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
ZNGA Zynga
$7.80 /

+0.06 (+0.78%)

VALE Vale
$13.36 /

-0.485 (-3.50%)

UNP Union Pacific
$231.36 /

+3.37 (+1.48%)

TSLA Tesla
$893.61 /

+28.625 (+3.31%)

TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

TCRR TCR2 Therapeutics
$6.84 /

-0.33 (-4.60%)

T AT&T
$25.75 /

-0.15 (-0.58%)

SPOT Spotify
$254.98 /

+3.88 (+1.55%)

SKLZ Skillz
$9.95 /

+0.78 (+8.51%)

RCI Rogers Communications
$48.63 /

-1.03 (-2.07%)

RBLX Roblox
$83.16 /

+4.495 (+5.71%)

PLD Prologis
$144.96 /

+1.54 (+1.07%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MU Micron
$68.63 /

+0.34 (+0.50%)

MTCH Match Group
$175.65 /

+16.58 (+10.42%)

LPSN LivePerson
$53.46 /

-3.68 (-6.44%)

INTC Intel
$56.01 /

+0.61 (+1.10%)

IBM IBM
$128.31 /

-13.48 (-9.51%)

FCX Freeport McMoRan
$38.43 /

-0.5 (-1.28%)

EFX Equifax
$255.57 /

-14.195 (-5.26%)

DENN Denny's
$15.40 /

+0.8 (+5.48%)

CROX Crocs
$148.57 /

+12.29 (+9.02%)

BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

BMBL Bumble
$56.27 /

+3.91 (+7.47%)

AN AutoNation
$125.99 /

+8.87 (+7.57%)

AMZN Amazon.com
$3,437.05 /

+24.73 (+0.72%)

  • 10
    Sep
  • 30
    Jun
  • 19
    Mar
  • 11
    Feb
  • 20
    Jan
ZNGA Zynga
$7.80 /

+0.06 (+0.78%)

VALE Vale
$13.36 /

-0.485 (-3.50%)

UNP Union Pacific
$231.36 /

+3.37 (+1.48%)

TSLA Tesla
$893.61 /

+28.625 (+3.31%)

T AT&T
$25.75 /

-0.15 (-0.58%)

SPOT Spotify
$254.98 /

+3.88 (+1.55%)

RCI Rogers Communications
$48.63 /

-1.03 (-2.07%)

RBLX Roblox
$83.16 /

+4.495 (+5.71%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MU Micron
$68.63 /

+0.34 (+0.50%)

MTCH Match Group
$175.65 /

+16.58 (+10.42%)

INTC Intel
$56.01 /

+0.61 (+1.10%)

IBM IBM
$128.31 /

-13.48 (-9.51%)

FCX Freeport McMoRan
$38.43 /

-0.5 (-1.28%)

DIDI Didi
$9.81 /

+1.195 (+13.88%)

DENN Denny's
$15.40 /

+0.8 (+5.48%)

CROX Crocs
$148.57 /

+12.29 (+9.02%)

BNTX BioNTech
$286.47 /

+16.78 (+6.22%)

BMBL Bumble
$56.27 /

+3.91 (+7.47%)

AMZN Amazon.com
$3,437.05 /

+24.73 (+0.72%)

ZNGA Zynga
$7.80 /

+0.06 (+0.78%)

UNP Union Pacific
$231.36 /

+3.37 (+1.48%)

TSLA Tesla
$893.61 /

+28.625 (+3.31%)

TCRR TCR2 Therapeutics
$6.84 /

-0.33 (-4.60%)

T AT&T
$25.75 /

-0.15 (-0.58%)

SKLZ Skillz
$9.95 /

+0.78 (+8.51%)

SHPW Shapeways
$9.65 /

-1.19 (-10.98%)

RCI Rogers Communications
$48.63 /

-1.03 (-2.07%)

RBLX Roblox
$83.16 /

+4.495 (+5.71%)

PLD Prologis
$144.96 /

+1.54 (+1.07%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MU Micron
$68.63 /

+0.34 (+0.50%)

MTCH Match Group
$175.65 /

+16.58 (+10.42%)

LPSN LivePerson
$53.46 /

-3.68 (-6.44%)

KDMN Kadmon
$9.42 /

+0.845 (+9.85%)

INTC Intel
$56.01 /

+0.61 (+1.10%)

FCX Freeport McMoRan
$38.43 /

-0.5 (-1.28%)

EFX Equifax
$255.57 /

-14.195 (-5.26%)

DWAC Digital World Acquisition
$45.77 /

+35.81 (+359.54%)

DIDI Didi
$9.81 /

+1.195 (+13.88%)

CROX Crocs
$148.57 /

+12.29 (+9.02%)

BMBL Bumble
$56.27 /

+3.91 (+7.47%)

AN AutoNation
$125.99 /

+8.87 (+7.57%)

AMZN Amazon.com
$3,437.05 /

+24.73 (+0.72%)

ZNGA Zynga
$7.80 /

+0.06 (+0.78%)

VALE Vale
$13.36 /

-0.485 (-3.50%)

UNP Union Pacific
$231.36 /

+3.37 (+1.48%)

TSLA Tesla
$893.61 /

+28.625 (+3.31%)

T AT&T
$25.75 /

-0.15 (-0.58%)

SPOT Spotify
$254.98 /

+3.88 (+1.55%)

SKLZ Skillz
$9.95 /

+0.78 (+8.51%)

SHPW Shapeways
$9.65 /

-1.19 (-10.98%)

RBLX Roblox
$83.16 /

+4.495 (+5.71%)

PFE Pfizer
$42.86 /

+0.07 (+0.16%)

MU Micron
$68.63 /

+0.34 (+0.50%)

MTCH Match Group
$175.65 /

+16.58 (+10.42%)

KDMN Kadmon
$9.42 /

+0.845 (+9.85%)

INTC Intel
$56.01 /

+0.61 (+1.10%)

IBM IBM
$128.31 /

-13.48 (-9.51%)

FCX Freeport McMoRan
$38.43 /

-0.5 (-1.28%)

EFX Equifax
$255.57 /

-14.195 (-5.26%)

DIDI Didi
$9.81 /

+1.195 (+13.88%)

CROX Crocs
$148.57 /

+12.29 (+9.02%)

BMBL Bumble
$56.27 /

+3.91 (+7.47%)

AMZN Amazon.com
$3,437.05 /

+24.73 (+0.72%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:32
10/21/21
10/21
12:32
10/21/21
12:32
TSLA

Tesla

$891.70 /

+26.72 (+3.09%)

, T

AT&T

$25.71 /

-0.19 (-0.73%)

, IBM

IBM

$130.07 /

-11.72 (-8.27%)

, PFE

Pfizer

$42.62 /

-0.17 (-0.40%)

, BNTX

BioNTech

$284.51 /

+14.82 (+5.50%)

, DWAC

Digital World Acquisition

$25.69 /

+15.73 (+157.93%)

, DIDI

Didi

$9.56 /

+0.95 (+11.03%)

, AMZN

Amazon.com

$3,427.51 /

+15.19 (+0.45%)

, MU

Micron

$67.90 /

-0.39 (-0.57%)

, FB

Facebook

$341.51 /

+0.56 (+0.16%)

, CG

Carlyle Group

$54.71 /

+1.21 (+2.26%)

, TSC

TriState Capital

$30.22 /

+7.49 (+32.95%)

, RJF

Raymond James

$98.68 /

-2.76 (-2.72%)

, KDMN

Kadmon

$9.39 /

+0.81 (+9.45%)

, SNY

Sanofi

$49.07 /

-0.06 (-0.12%)

, SKLZ

Skillz

$9.96 /

+0.79 (+8.62%)

, VALE

Vale

$13.06 /

-0.785 (-5.67%)

, SHPW

Shapeways

$9.07 /

-1.77 (-16.33%)

, AN

AutoNation

$124.42 /

+7.3 (+6.23%)

, CROX

Crocs

$145.75 /

+9.47 (+6.95%)

, EFX

Equifax

$260.66 /

-9.1 (-3.37%)

, FCX

Freeport McMoRan

$37.90 /

-1.03 (-2.65%)

, UNP

Union Pacific

$228.45 /

+0.46 (+0.20%)

, LPSN

LivePerson

$52.30 /

-4.84 (-8.47%)

, PLD

Prologis

$144.21 /

+0.79 (+0.55%)

, DENN

Denny's

$15.46 /

+0.86 (+5.89%)

, TCRR

TCR2 Therapeutics

$6.88 /

-0.295 (-4.11%)

, MTCH

Match Group

$165.86 /

+6.79 (+4.27%)

, GOOGL

Alphabet Class A

$2,823.70 /

-11.32 (-0.40%)

, GOOG

Alphabet

$2,844.15 /

-1.85 (-0.07%)

Get caught up quickly on…

ShowHide Related Items >><<
VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

TSC TriState Capital
$30.22 /

+7.49 (+32.95%)

TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

RJF Raymond James
$98.68 /

-2.76 (-2.72%)

PLD Prologis
$144.21 /

+0.79 (+0.55%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

LPSN LivePerson
$52.30 /

-4.84 (-8.47%)

KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DWAC Digital World Acquisition
$25.69 /

+15.73 (+157.93%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

DENN Denny's
$15.46 /

+0.86 (+5.89%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AN AutoNation
$124.42 /

+7.3 (+6.23%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

10/21/21 RBC Capital
Tesla price target raised to $800 from $755 at RBC Capital
10/21/21 Credit Suisse
Tesla price target raised to $830 from $800 at Credit Suisse
10/21/21 Wedbush
Tesla price target raised to $1,100 from $1,000 at Wedbush
10/21/21 Roth Capital
Tesla price target raised to $250 from $150 at Roth Capital
T AT&T
$25.71 /

-0.19 (-0.73%)

10/19/21 Citi
AT&T price target lowered to $30 from $32 at Citi
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
IBM IBM
$130.07 /

-11.72 (-8.27%)

10/21/21 Morgan Stanley
IBM's Q3 'a pause on the path to improving growth,' says Morgan Stanley
10/06/21 Evercore ISI
IBM removed from Tactical Outperform list at Evercore ISI
10/05/21 Credit Suisse
IBM price target raised to $176 from $167 at Credit Suisse
10/01/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$42.62 /

-0.17 (-0.40%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
DWAC Digital World Acquisition
$25.69 /

+15.73 (+157.93%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
10/20/21 Bernstein
Amazon.com may be more sheltered from broader sector declines, says Bernstein
10/13/21 Baird
Amazon.com weakness would be a buying opportunity, says Baird
10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
MU Micron
$67.90 /

-0.39 (-0.57%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
FB Facebook
$341.51 /

+0.56 (+0.16%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 BMO Capital
Carlyle Group upgraded to Outperform from Market Perform at BMO Capital
08/11/21 Deutsche Bank
Carlyle Group upgraded to Buy on durable earnings power at Deutsche Bank
08/11/21 Deutsche Bank
Carlyle Group upgraded to Buy from Hold at Deutsche Bank
TSC TriState Capital
$30.22 /

+7.49 (+32.95%)

07/23/21 B. Riley
TriState Capital price target raised to $28 from $26 at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy on share pullback at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy from Neutral at B. Riley
04/26/21 B. Riley
TriState Capital price target raised to $26 from $21 at B. Riley
RJF Raymond James
$98.68 /

-2.76 (-2.72%)

10/21/21 JMP Securities
Raymond James price target raised to $112 from $103 at JMP Securities
10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 Jefferies
Kadmon downgraded to Hold from Buy at Jefferies
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
SNY Sanofi
$49.07 /

-0.06 (-0.12%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

08/04/21 Canaccord
Skillz price target lowered to $23 from $30 at Canaccord
08/04/21 Wedbush
Skillz price target lowered to $25 from $34 at Wedbush
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 RBC Capital
Skillz initiated with a Sector Perform at RBC Capital
VALE Vale
$13.06 /

-0.785 (-5.67%)

10/21/21 RBC Capital
Vale double-downgraded to Underperform from Outperform at RBC Capital
10/21/21 RBC Capital
Vale downgraded to Underperform from Outperform at RBC Capital
10/20/21 Jefferies
Jefferies downgrades trio of iron ore miners on near-term downside risk
10/20/21 Jefferies
Vale downgraded to Hold from Buy at Jefferies
SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

07/28/21 Lake Street
Galileo Acquisition Corp. initiated with a Buy at Lake Street
AN AutoNation
$124.42 /

+7.3 (+6.23%)

09/28/21 Morgan Stanley
AutoNation upgraded to Equal Weight from Underweight at Morgan Stanley
07/20/21 Truist
AutoNation price target raised to $110 from $100 at Truist
07/16/21 BofA
AutoNation price target raised to $171 from $161 at BofA
04/22/21
Fly Intel: Top five analyst upgrades
CROX Crocs
$145.75 /

+9.47 (+6.95%)

10/21/21 Piper Sandler
Crocs price target raised to $215 from $212 at Piper Sandler
10/19/21 Baird
Crocs remains an underappreciated story with positive setup, says Baird
10/08/21 Piper Sandler
Crocs pullback an opportunity to own best-in-class story, says Piper Sandler
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
EFX Equifax
$260.66 /

-9.1 (-3.37%)

10/14/21 Evercore ISI
Equifax resumed with an Outperform at Evercore ISI
10/14/21 Needham
Equifax price target raised to $295 from $288 at Needham
08/17/21 Barclays
Equifax price target raised to $330 from $285 at Barclays
07/28/21 Barclays
Equifax price target raised to $285 from $270 at Barclays
FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

10/06/21 Exane BNP Paribas
Freeport McMoRan upgraded to Outperform from Neutral at Exane BNP Paribas
09/29/21 BofA
Freeport McMoRan reinstated with a Buy at BofA
09/28/21 Morgan Stanley
Freeport McMoRan price target lowered to $32 from $37 at Morgan Stanley
09/16/21 Deutsche Bank
Freeport McMoRan price target lowered to $46 from $47 at Deutsche Bank
UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

10/08/21
Fly Intel: Top five analyst upgrades
10/08/21 JPMorgan
Union Pacific upgraded to Overweight on recent selloff at JPMorgan
10/08/21 JPMorgan
Union Pacific upgraded to Overweight from Neutral at JPMorgan
10/04/21
Fly Intel: Top five analyst upgrades
LPSN LivePerson
$52.30 /

-4.84 (-8.47%)

10/21/21
Fly Intel: Top five analyst downgrades
10/21/21 Barclays
LivePerson downgraded to Underweight from Overweight at Barclays
09/17/21 Barclays
LivePerson price target raised to $80 from $76 at Barclays
07/01/21
Fly Intel: Top five analyst initiations
PLD Prologis
$144.21 /

+0.79 (+0.55%)

10/21/21
Fly Intel: Top five analyst upgrades
10/21/21 Goldman Sachs
Prologis upgraded to Conviction Buy from Buy at Goldman Sachs
10/20/21 BTIG
Prologis price target raised to $161 from $146 at BTIG
10/19/21 Barclays
Prologis price target raised to $161 from $159 at Barclays
DENN Denny's
$15.46 /

+0.86 (+5.89%)

10/21/21 Truist
Denny's upgraded to Buy from Hold at Truist
10/20/21 Truist
Denny's upgraded to Buy from Hold at Truist
10/08/21
Fly Intel: Top five analyst initiations
10/08/21 Deutsche Bank
Denny's initiated with Hold, $17 target at Deutsche Bank
TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

10/21/21 BMO Capital
TCR2 Therapeutics price target lowered to $38 from $44 at BMO Capital
10/21/21 Mizuho
TCR2 Therapeutics price target lowered to $20 from $51 at Mizuho
10/21/21 SVB Leerink
SVB Leerink downgrades TCR2 on 'protracted road' to recovery
10/20/21 SVB Leerink
TCR2 Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
MTCH Match Group
$165.86 /

+6.79 (+4.27%)

10/12/21 Jefferies
Jefferies positive on Q3 set-up for Match Group and Bumble
08/05/21 Morgan Stanley
Morgan Stanley buyers of Match Group on post-earnings pullback
07/21/21 Truist
Match Group price target raised to $190 from $160 at Truist
07/09/21
Fly Intel: Top five analyst initiations
GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

10/21/21 Stephens
Roku sits in 'more enviable' position in fight over YouTube TV, says Stephens
10/21/21 Mizuho
Alphabet price target raised to $3,100 from $3,000 at Mizuho
10/20/21 Barclays
Zoom Video initiated with an Equal Weight at Barclays
GOOG Alphabet
$2,844.15 /

-1.85 (-0.07%)

VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

TSC TriState Capital
$30.22 /

+7.49 (+32.95%)

TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

RJF Raymond James
$98.68 /

-2.76 (-2.72%)

PLD Prologis
$144.21 /

+0.79 (+0.55%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

LPSN LivePerson
$52.30 /

-4.84 (-8.47%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DENN Denny's
$15.46 /

+0.86 (+5.89%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AN AutoNation
$124.42 /

+7.3 (+6.23%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

  • 30
    Jun
  • 19
    May
  • 19
    Mar
  • 12
    Mar
  • 20
    Jan
VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

RJF Raymond James
$98.68 /

-2.76 (-2.72%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

DENN Denny's
$15.46 /

+0.86 (+5.89%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

PLD Prologis
$144.21 /

+0.79 (+0.55%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DWAC Digital World Acquisition
$25.69 /

+15.73 (+157.93%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AN AutoNation
$124.42 /

+7.3 (+6.23%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

Hot Stocks
Kadmon says HSR waiting period expired without letter from FTC » 09:40
10/21/21
10/21
09:40
10/21/21
09:40
KDMN

Kadmon

$8.60 /

+0.025 (+0.29%)

, SNY

Sanofi

$49.11 /

-0.02 (-0.04%)

In a regulatory filing…

In a regulatory filing earlier, Kadmon (KDMN) noted that completion of its previously disclosed merger with Sanofi (SNY) is conditioned upon, among other things, the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and as of the end of the HSR waiting period, neither Sanofi nor the company having received a standard form letter from the Federal Trade Commission Bureau of Competition, in the form announced and disclosed by the FTC on August 3, 2021. "The HSR waiting period expired on October 20, 2021 at 11:59 p.m. Eastern Time with neither the company nor Sanofi having received a Form Letter from the FTC," the company stated in its filing with the SEC.

ShowHide Related Items >><<
SNY Sanofi
$49.11 /

-0.02 (-0.04%)

KDMN Kadmon
$8.60 /

+0.025 (+0.29%)

KDMN Kadmon
$8.60 /

+0.025 (+0.29%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 Jefferies
Kadmon downgraded to Hold from Buy at Jefferies
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
SNY Sanofi
$49.11 /

-0.02 (-0.04%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SNY Sanofi
$49.11 /

-0.02 (-0.04%)

SNY Sanofi
$49.11 /

-0.02 (-0.04%)

SNY Sanofi
$49.11 /

-0.02 (-0.04%)

KDMN Kadmon
$8.60 /

+0.025 (+0.29%)

KDMN Kadmon
$8.60 /

+0.025 (+0.29%)

Options
Unusually active option classes on open October 21st » 09:40
10/21/21
10/21
09:40
10/21/21
09:40
GSK

GlaxoSmithKline

$39.44 /

+0.005 (+0.01%)

, CROX

Crocs

$136.28 /

+ (+0.00%)

, HON

Honeywell

$223.60 /

-0.02 (-0.01%)

, PYPL

PayPal

$258.00 /

+0.02 (+0.01%)

, VFC

VF Corp.

$73.96 /

+ (+0.00%)

, SESN

Sesen Bio

$1.27 /

+ (+0.00%)

, AMRS

Amyris

$13.45 /

+ (+0.00%)

, DIDI

Didi

$8.61 /

+ (+0.00%)

, SOS

SOS Limited

$2.76 /

+ (+0.00%)

, HPQ

HP Inc.

$28.59 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: GlaxoSmithKline (GSK), Crocs (CROX), Honeywell (HON), PayPal (PYPL), V F Corp (VFC), Sesen Bio (SESN), Amyris (AMRS), DiDi Global (DIDI), SOS Limited (SOS), and HP Inc. (HPQ).

ShowHide Related Items >><<
VFC VF Corp.
$73.96 /

+ (+0.00%)

SOS SOS Limited
$2.76 /

+ (+0.00%)

SESN Sesen Bio
$1.27 /

+ (+0.00%)

PYPL PayPal
$258.00 /

+0.02 (+0.01%)

HPQ HP Inc.
$28.59 /

+ (+0.00%)

HON Honeywell
$223.60 /

-0.02 (-0.01%)

GSK GlaxoSmithKline
$39.44 /

+0.005 (+0.01%)

DIDI Didi
$8.61 /

+ (+0.00%)

CROX Crocs
$136.28 /

+ (+0.00%)

AMRS Amyris
$13.45 /

+ (+0.00%)

GSK GlaxoSmithKline
$39.44 /

+0.005 (+0.01%)

10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/04/21 Alliance Global Partners
Achieve Life Sciences initiated with a Buy at Alliance Global Partners
CROX Crocs
$136.28 /

+ (+0.00%)

10/19/21 Baird
Crocs remains an underappreciated story with positive setup, says Baird
10/08/21 Piper Sandler
Crocs pullback an opportunity to own best-in-class story, says Piper Sandler
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
09/15/21 Monness Crespi
Crocs price target raised to $180 from $160 at Monness Crespi
HON Honeywell
$223.60 /

-0.02 (-0.01%)

10/07/21 Wells Fargo
Honeywell initiated with an Equal Weight at Wells Fargo
09/10/21 Gordon Haskett
Gordon Haskett says three Honeywell jets spotted near Hexcel HQ
07/26/21 Deutsche Bank
Honeywell price target raised to $251 from $245 at Deutsche Bank
07/26/21 Barclays
Honeywell price target raised to $253 from $245 at Barclays
PYPL PayPal
$258.00 /

+0.02 (+0.01%)

10/21/21 Credit Suisse
Rationale for acquiring Pinterest vs. partnership less clear, says Credit Suisse
10/21/21 Deutsche Bank
Deutsche 'intrigued' by strategic possibilities of PayPal buying Pinterest
10/20/21 Bernstein
PayPayl, Pinterest 'is a match NOT made in heaven,' says Bernstein
10/20/21 Keefe Bruyette
Pinterest purchase 'can make sense' for PayPal, says Keefe Bruyette
VFC VF Corp.
$73.96 /

+ (+0.00%)

10/18/21 Deutsche Bank
VF Corp. price target lowered to $95 from $106 at Deutsche Bank
10/08/21 OTR Global
VF Corp. view downgraded to Mixed from Positive at OTR Global
10/05/21 Cowen
VF Corp. price target lowered to $83 from $94 at Cowen
SESN Sesen Bio
$1.27 /

+ (+0.00%)

08/17/21 Canaccord
Sesen Bio price target lowered to $3 from $7 at Canaccord
08/16/21 H.C. Wainwright
Sesen Bio downgraded to Neutral from Buy at H.C. Wainwright
07/22/21 Canaccord
Sesen Bio approval of Vicineum expected August 18, says Canaccord
02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
AMRS Amyris
$13.45 /

+ (+0.00%)

10/14/21 Cowen
Amyris coverage transferred at Cowen
08/06/21 H.C. Wainwright
Amyris price target lowered to $30 from $35 at H.C. Wainwright
07/06/21 HSBC
Amyris is at 'tipping point on growth,' says HSBC
06/01/21 HSBC
Amyris initiated with a Buy at HSBC
DIDI Didi
$8.61 /

+ (+0.00%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
SOS SOS Limited
$2.76 /

+ (+0.00%)

HPQ HP Inc.
$28.59 /

+ (+0.00%)

09/29/21
Fly Intel: Top five analyst downgrades
09/29/21 JPMorgan
HP Inc. downgraded to Neutral from Overweight at JPMorgan
08/27/21
Fly Intel: Top five analyst downgrades
08/27/21 Morgan Stanley
Morgan Stanley prefers Dell to HP, ups price target to $133
VFC VF Corp.
$73.96 /

+ (+0.00%)

SESN Sesen Bio
$1.27 /

+ (+0.00%)

PYPL PayPal
$258.00 /

+0.02 (+0.01%)

HPQ HP Inc.
$28.59 /

+ (+0.00%)

HON Honeywell
$223.60 /

-0.02 (-0.01%)

GSK GlaxoSmithKline
$39.44 /

+0.005 (+0.01%)

CROX Crocs
$136.28 /

+ (+0.00%)

AMRS Amyris
$13.45 /

+ (+0.00%)

  • 30
    Jun
  • 09
    Apr
PYPL PayPal
$258.00 /

+0.02 (+0.01%)

HPQ HP Inc.
$28.59 /

+ (+0.00%)

HON Honeywell
$223.60 /

-0.02 (-0.01%)

GSK GlaxoSmithKline
$39.44 /

+0.005 (+0.01%)

DIDI Didi
$8.61 /

+ (+0.00%)

CROX Crocs
$136.28 /

+ (+0.00%)

AMRS Amyris
$13.45 /

+ (+0.00%)

VFC VF Corp.
$73.96 /

+ (+0.00%)

SESN Sesen Bio
$1.27 /

+ (+0.00%)

PYPL PayPal
$258.00 /

+0.02 (+0.01%)

HPQ HP Inc.
$28.59 /

+ (+0.00%)

HON Honeywell
$223.60 /

-0.02 (-0.01%)

GSK GlaxoSmithKline
$39.44 /

+0.005 (+0.01%)

DIDI Didi
$8.61 /

+ (+0.00%)

CROX Crocs
$136.28 /

+ (+0.00%)

AMRS Amyris
$13.45 /

+ (+0.00%)

VFC VF Corp.
$73.96 /

+ (+0.00%)

SOS SOS Limited
$2.76 /

+ (+0.00%)

SESN Sesen Bio
$1.27 /

+ (+0.00%)

PYPL PayPal
$258.00 /

+0.02 (+0.01%)

HPQ HP Inc.
$28.59 /

+ (+0.00%)

HON Honeywell
$223.60 /

-0.02 (-0.01%)

GSK GlaxoSmithKline
$39.44 /

+0.005 (+0.01%)

DIDI Didi
$8.61 /

+ (+0.00%)

CROX Crocs
$136.28 /

+ (+0.00%)

AMRS Amyris
$13.45 /

+ (+0.00%)

Hot Stocks
Pfizer, BioNTech say Covid-19 booster restores efficacy to 95.6% in trial » 06:47
10/21/21
10/21
06:47
10/21/21
06:47
PFE

Pfizer

$42.79 /

+0.7 (+1.66%)

, BNTX

BioNTech

$269.68 /

+6.7 (+2.55%)

Pfizer Inc. (PFE) and…

Pfizer Inc. (PFE) and BioNTech (BNTX) announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-microgram booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 years of age and older. In the trial, a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series restored vaccine protection against COVID-19 to the high levels achieved after the second dose, showing a relative vaccine efficacy of 95.6% when compared to those who did not receive a booster. These are the first efficacy results from any randomized, controlled COVID-19 vaccine booster trial. "These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease," said Albert Bourla, Chairman and CEO, Pfizer. "In addition to our efforts to increase global access and uptake among the unvaccinated, we believe boosters have a critical role to play in addressing the ongoing public health threat of this pandemic. We look forward to sharing these data with health authorities and working together to determine how they can be used to support the rollout of booster doses around the world." All trial participants previously completed the primary two-dose series of the Pfizer-BioNTech vaccine, and then were randomized 1:1 to receive either a 30-microgram booster dose or placebo. The median time between second dose and administration of the booster dose or placebo was approximately 11 months. Symptomatic COVID-19 occurrence was measured from at least 7 days after booster or placebo, with a median follow-up of 2.5 months. During the study period, there were 5 cases of COVID-19 in the boosted group, and 109 cases in the non-boosted group. The observed relative vaccine efficacy of 95.6% reflects the reduction in disease occurrence in the boosted group versus the non-boosted group in those without evidence of prior SARS-CoV-2 infection. Median age of participants was 53 years, with 55.5% of participants between 16 and 55 years, and 23.3% of participants 65 years and older.

ShowHide Related Items >><<
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

Hot Stocks
Pfizer, BioNTech: Covid-19 booster restores efficacy to 95.6% in trial  06:46
10/21/21
10/21
06:46
10/21/21
06:46
PFE

Pfizer

$42.79 /

+0.7 (+1.66%)

, BNTX

BioNTech

$269.68 /

+6.7 (+2.55%)

 
ShowHide Related Items >><<
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

BNTX BioNTech
$269.68 /

+6.7 (+2.55%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.